You are here: Industry Insights > Products Guide > Urgent Sourcing Needs of【PharmaSources.com】2020.9.14

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

CBZ-L-Valganciclovir

4-Bromo-3-nitroanisole

PF-680Adjustable Cellophane Tri-dimensiona Overwrapping Machine (with tear type)

2-Chlorophenothiazine

Flibanserin

its control software

Urgent Sourcing Needs of【PharmaSources.com】2020.9.14

PharmaSources.comSeptember 14, 2020

Tag: Sourcing Needs , Product List , PharmaSources.com

Favorites

【PharmaSources.com】provides the free-of-charge One-to-One Matching Service every week. Your dedicated client service officer collects your sourcing needs and searches suitable suppliers for you to improve your sourcing efficiency greatly.

The validity of the sourcing needs lasts one week.

If your company could provide the following medical devices and supplies, you can email the product name to Freya. She will reply you with the detailed information including the buyers' contact information.

Contact Person: Freya.Yao

Email: Freya.Yao@ubmsinoexpo.com

Tel: 86-21-33392401

Previous:Genome analyses track SARS-CoV-2's early introduction to the US and Europe

Next:MSF urges government authorities to include patented drugs in upcoming NLEM

Popular Products and Companies at PharmaSources.com (January 2025)

PSIJanuary 15, 2025

Popular Products and Companies at PharmaSources.com

Research and Application of Artemisia Argyi

XiaonishaAugust 12, 2024

Research Progress on the Application of Biologics in Pediatric Asthma

XiaomichongJuly 19, 2024

Urgent Sourcing Needs of【PharmaSources.com】2020.9.14 | Pharmasources.com

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

XiaomichongJuly 19, 2024

Artemisinin is a sesquiterpene lactone compound with a peroxide group structure extracted from the leaves of Artemisia annua, a plant belonging to the Asteraceae family.